Effects of Combined Treatment With Rapamycin and Cotylenin A, a Novel Differentiation-Inducing Agent, on Human Breast Carcinoma McF-7 Cells and Xenografts

Breast Cancer Research - United Kingdom
doi 10.1186/bcr1344
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search